GlassScriptPhysician profile
Keri Wong
NPI 1639321284
$8,817.04
in general payments reported to CMS, 2019-2025
25 companies · $717 in 2025
The $717 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,457 · 2020: $558 · 2021: $3,232 · 2022: $963 · 2023: $415 · 2024: $474 · 2025: $717.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,541 · Education: $65.21.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,540.71 |
| Education | $65.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Caldera Medical, INC | $3,826.02 | 2019-2025 | Desara |
| Intuitive Surgical, INC. | $3,027.08 | 2021 | |
| Medtronic, INC. | $502.17 | 2022 | |
| Astellas Pharma US INC | $238.42 | 2019-2023 | Myrbetriq |
| Axonics, INC. | $183.83 | 2022-2024 | Axonics |
| Coopersurgical, INC. | $119.17 | 2025 | Onetrac Lx |
| Femselect INC. | $106.89 | 2025 | Enplace |
| Medtronic USA, INC. | $106.05 | 2020 | |
| Coloplast Corp | $99.19 | 2019-2022 | |
| Janssen Biotech, INC. | $82.87 | 2025 | Erleada |
| Progenics Pharmaceuticals, INC. | $81.14 | 2024-2025 | |
| Patterson Companies, INC. | $65.21 | 2023 | |
| Boston Scientific Corporation | $53.04 | 2020-2022 | |
| Ferring Pharmaceuticals INC. | $47.89 | 2025 | Adstiladrin |
| Abbvie INC. | $44.85 | 2024 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $41.58 | 2019-2025 | Aptima |
| Olympus America INC. | $35.07 | 2022 | |
| Merck Sharp & Dohme LLC | $29.24 | 2024 | Keytruda |
| Bayer Healthcare Pharmaceuticals INC. | $23.82 | 2025 | |
| Endo USA, INC. | $23.74 | 2025 | Xiaflex, Aveed |
| Verity Pharmaceuticals INC. | $19.65 | 2023 | Trelstar |
| Inspire Medical Systems, INC. | $18.63 | 2023 | Inspire |
| Convatec INC. | $15.95 | 2021 | |
| Therapeuticsmd, INC. | $14.36 | 2019 | |
| Rochester Medical Corporation | $11.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keri Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.